Simon Tate - Jun 26, 2024 Form 4 Insider Report for Eliem Therapeutics, Inc. (ELYM)

Role
Director
Signature
/s/ William Cowles, Attorney-in-Fact
Stock symbol
ELYM
Transactions as of
Jun 26, 2024
Transactions value $
$0
Form type
4
Date filed
6/28/2024, 05:13 PM
Previous filing
May 22, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELYM Stock Option (Right To Buy) Award $0 +10K $0.00 10K Jun 26, 2024 Common Stock 10K $7.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option will vest on the earlier of June 26, 2025 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date.